U.S. Medical Imaging Market Size & Share 2025 – 2034
Market Size by Product, by End Use, Forecast.
Download Free PDF
Market Size by Product, by End Use, Forecast.
Download Free PDF
Starting at: $1,950
Base Year: 2024
Companies Profiled: 11
Tables & Figures: 41
Countries Covered: 1
Pages: 65
Download Free PDF
U.S. Medical Imaging Market
Get a free sample of this report
U.S. Medical Imaging Market Size
The U.S. medical imaging market was valued at USD 15.1 billion in 2024 and is projected to increase from USD 15.8 billion in 2025 to USD 24.9 billion by 2034, registering a CAGR of 5.2%, according to the latest report published by Global Market Insights Inc.
U.S. Medical Imaging Market Key Takeaways
Market Size & Growth
Key Market Drivers
Challenges
Opportunity
Key Players
The growth of the U.S. medical imaging market is stimulated by several factors, including rising disease burden, technological advancement of medical imaging systems, and growing healthcare expenditure in U.S. Medical imaging uses various technologies in order to create visual representations of the interior part of the body for medical intervention and clinical analysis. Key players in this market include GE HealthCare Technologies, Siemens Healthineers, Koninklijke Philips, Canon Medical Systems, and Fujifilm Holdings.
The market size increased from USD 13.3 billion in 2021 to USD 14.5 billion in 2023, primarily due to the expanding geriatric population. As individuals age, they become more susceptible to chronic illnesses such as cardiovascular diseases, osteoporosis, and cancer, which require frequent hospitalizations and diagnostic procedures. Medical imaging technologies, including MRI, CT scans, and X-rays, are essential in diagnosing and monitoring these conditions, accelerating the demand for advanced medical imaging solutions.
For instance, according to the data from National Council on Aging, in 2022, the U.S. had 57.8 million adults aged 65 and older, comprising 31.9 million women and 25.9 million men. Among this population, 25% belonged to racially and ethnically diverse communities, demonstrating broad demographic impact. States such as Maine, Florida, West Virginia, and Vermont reported the highest proportion of elderly residents, indicating regions with significant healthcare demands. The increasing elderly population is stimulating the need for advanced imaging tools, establishing medical imaging as an essential component of modern healthcare. Moreover, the market continues to expand as hospitals and clinics respond to this demand, supported by technological advancements and rising patient volumes requiring imaging-based care.
Additionally, the rising incidence of chronic disease is one of the major factors accelerating the growth of the U.S. medical imaging market. Conditions such as Alzheimer's disease, cancer, and cardiovascular diseases, among others, require continuous monitoring, early diagnosis, and precise treatment planning, all of which depend heavily on advanced imaging technology. For instance, in 2025, nearly 7.2 million U.S. citizens aged 65 and older are living with Alzheimer's disease, according to the Alzheimer's Association. These figures highlight the urgent need for technologically advanced diagnostic imaging tools for early detection of neurological changes, tracking disease progression, and supporting clinical decision-making in managing Alzheimer's and related conditions, thereby fostering market growth in the country.
Medical imaging uses various technologies in order to create visual representations of the interior parts of the body for medical intervention and clinical analysis. These imaging technologies help healthcare professionals monitor and diagnose diseases, assess injuries, and guide treatment plans by providing detailed images of tissues, organs, and bones. Common medical imaging devices include CT scanner, medical X-ray, magnetic resonance imaging (MRI) systems, ultrasound, and other medical imaging devices.
U.S. Medical Imaging Market Trends
U.S. Medical Imaging Market Analysis
The market was valued at USD 13.3 billion in 2021. The market size reached USD 14.5 billion in 2023, from USD 14 billion in 2022.
Based on the product, the U.S. medical imaging market is segmented into X-ray devices, MRI, ultrasound, computed tomography, nuclear imaging, and mammography. The X-ray devices segment dominated the market in 2024. This segment was valued at USD 4.6 billion in 2024 and is projected to reach USD 7.4 billion by 2034, growing at a CAGR of 4.9%. In comparison, the MRI segment, valued at USD 2.3 billion in 2024, is expected to grow to USD 4.1 billion by 2034, with a CAGR of 6%.
Based on end use, the U.S. medical imaging market is segmented into hospitals, diagnostic centers, and other end users. The hospitals segment accounted for the highest market share of 52.6% in 2024.
U.S. Medical Imaging Market Share
U.S. Medical Imaging Market Companies
Few of the prominent players operating in the U.S. medical imaging industry include:
Siemens Healthineers AG is a leader in developing and manufacturing a wide array of healthcare products and solutions aimed at enhancing patient outcomes across various medical disciplines. The company delivers innovative technologies across multiple segments, including in-vitro diagnostics for laboratories, hospitals, and point-of-care testing. Operating through regional subsidiaries in Germany, the U.S., Asia, and over 70 other countries, Siemens Healthineers continues to advance healthcare delivery. Its focus remains on transforming patient care through cutting-edge medical technologies and a commitment to improving lives worldwide.
Shimadzu operates in over 100 countries through a network of subsidiaries and offices across the Americas, Europe, Asia, and other regions. The company offers advanced diagnostic imaging solutions designed to enhance clinical precision and improve workflow efficiency, particularly in surgical and interventional procedures.
Hologic medical technology company specializing in diagnostic imaging systems, surgical devices, and molecular diagnostics, with a strong focus on women’s health. Headquartered in Marlborough, Massachusetts, Hologic serves hospitals and clinics across the U.S. through direct operations and strategic partnerships. The company leads in breast health and diagnostics, contributing significantly to the U.S. medical imaging market.
40.2% Market share
Collective market share in 2024 is 96%
U.S. Medical Imaging Industry News:
The U.S. medical imaging market research report includes an in-depth coverage of the industry with estimates and forecast in terms of revenue in USD Million and from 2021 -2034 for the following segments:
Click here to Buy Section of this Report
Market, By Product
Market, By End Use
Research methodology, data sources & validation process
This report draws on a structured research process built around direct industry conversations, proprietary modelling, and rigorous cross-validation and not just desk research.
Our 6-step research process
1. Research design & analyst oversight
At GMI, our research methodology is built on a foundation of human expertise, rigorous validation, and complete transparency. Every insight, trend analysis, and forecast in our reports is developed by experienced analysts who understand the nuances of your market.
Our approach integrates extensive primary research through direct engagement with industry participants and experts, complemented by comprehensive secondary research from verified global sources. We apply quantified impact analysis to deliver dependable forecasts, while maintaining complete traceability from original data sources to final insights.
2. Primary research
Primary research forms the backbone of our methodology, contributing nearly 80% to overall insights. It involves direct engagement with industry participants to ensure accuracy and depth in analysis. Our structured interview program covers regional and global markets, with inputs from C-suite executives, directors, and subject matter experts. These interactions provide strategic, operational, and technical perspectives, enabling well-rounded insights and reliable market forecasts.
3. Data mining & market analysis
Data mining is a key part of our research process, contributing nearly 20% to the overall methodology. It involves analysing market structure, identifying industry trends, and assessing macroeconomic factors through revenue share analysis of major players. Relevant data is collected from both paid and unpaid sources to build a reliable database. This information is then integrated to support primary research and market sizing, with validation from key stakeholders such as distributors, manufacturers, and associations.
4. Market sizing
Our market sizing is built on a bottom-up approach, starting with company revenue data gathered directly through primary interviews, alongside production volume figures from manufacturers and installation or deployment statistics. These inputs are then pieced together across regional markets to arrive at a global estimate that stays grounded in actual industry activity.
5. Forecast model & key assumptions
Every forecast includes explicit documentation of:
✓ Key growth drivers and their assumed impact
✓ Restraining factors and mitigation scenarios
✓ Regulatory assumptions and policy change risk
✓ Technology adoption curve parameter
✓ Macroeconomic assumptions (GDP growth, inflation, currency)
✓ Competitive dynamics and market entry/exit expectations
6. Validation & quality assurance
The final stages involve human validation, where domain experts manually review filtered data to identify nuances and contextual errors that automated systems might miss. This expert review adds a critical layer of quality assurance, ensuring data aligns with research objectives and domain-specific standards.
Our triple-layer validation process ensures maximum data reliability:
✓ Statistical Validation
✓ Expert Validation
✓ Market Reality Check
Trust & credibility
Verified data sources
Trade publications
Security & defense sector journals and trade press
Industry databases
Proprietary and third-party market databases
Regulatory filings
Government procurement records and policy documents
Academic research
University studies and specialist institution reports
Company reports
Annual reports, investor presentations, and filings
Expert interviews
C-suite, procurement leads, and technical specialists
GMI archive
13,000+ published studies across 30+ industry verticals
Trade data
Import/export volumes, HS codes, and customs records
Parameters studied & evaluated
Every data point in this report is validated through primary interviews, true bottom-up modelling, and rigorous cross-checks. Read about our research process →